The Chugai drug starts with a strike against it I think because there are a couple of mutations it very likely can't handle.
'113 in theory should be able to handle the known mutations (except perhaps I1171N, which none of the disclosed drugs can handle well), although some have raised doubts about G1202R.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.